Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05078229 · ClinicalTrials.gov registry record · NA

Evaluating Stress Management Among Allogeneic HCT Caregivers

A NA study of Stress and Burden, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Active
Registry status
NA
Development phase
505
Enrollment target
1
Study location

NCT05078229: Active NA study of Stress and Burden, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

NCT05078229 is a NA study of Stress and Burden that is active but no longer recruiting, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 505 participants, below the 783-participant average among 152 other Stress trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05078229, a NA study of Stress and Burden, is active but no longer recruiting, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
505 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to understand whether different stress management interventions impact stress among HCT cancer caregivers and patients.

Conditions Studied

Interventions

  • BEHAVIORAL Healthy Living
  • BEHAVIORAL FOCUS

Study Locations (1)

Florida

  • Moffitt Cancer Center - Tampa

Trial Details

FieldValue
Enrollment Target 505 participants
Start Date 2021-09-16
Est. Completion 2026-03-31
Phase NA

What the Registry Record Tells You About NCT05078229

The ClinicalTrials.gov registry entry for NCT05078229 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 505 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 783-participant average among 152 other Stress trials with a reported enrollment target (36% lower). The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Stress appearing as the primary indexed condition, and to 2 interventions - of which Healthy Living is the first listed.

NCT05078229 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05078229 about?

NCT05078229 is a clinical study titled "Evaluating Stress Management Among Allogeneic HCT Caregivers". The purpose of the study is to understand whether different stress management interventions impact stress among HCT cancer caregivers and patients.

What is the current status of trial NCT05078229?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 505 participants. The study started on 2021-09-16. Estimated completion is 2026-03-31.

What conditions does trial NCT05078229 study?

This clinical trial studies the following conditions: Stress, Burden.

What interventions are being tested in trial NCT05078229?

The interventions under investigation include: Healthy Living (BEHAVIORAL), FOCUS (BEHAVIORAL).

Who is sponsoring clinical trial NCT05078229?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05078229 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.